David Hipkiss

David Hipkiss

Voorzitter bij
AlveoGene Ltd.
56 jaar
Process Industries
Health Technology
Finance

Profiel

David John Hipkiss was the founder of Prosonix Ltd. which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2012.
He is currently the Chairman of AlveoGene Ltd. since 2023.
Mr. Hipkiss's former jobs include being the Chief Executive Officer & Director of Enesi Pharma Ltd., a Principal at Air Products & Chemicals, Inc. and The Dow Chemical Co., the General Manager of Accentus LLC and Accentus Medical Ltd., a Principal at Chirotech Technology Ltd. and Ascot Plc, and the Chief Business Officer of Niox Group Plc.
Mr. Hipkiss received an undergraduate degree from the University of Birmingham.

Actieve functies van David Hipkiss

BedrijvenFunctieBegin
Voorzitter 01-07-2023

Eerdere bekende functies van David Hipkiss

BedrijvenFunctieEinde
Corporate Officer/Principal -
Algemeen Directeur 01-07-2022
Ascot Plc
Corporate Officer/Principal -
NIOX GROUP PLC Corporate Officer/Principal -
AIR PRODUCTS & CHEMICALS, INC. Corporate Officer/Principal -
Ervaring van David Hipkiss in detail bekijken

Opleiding van David Hipkiss

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

4

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Process Industries

Process Industries

Technology Services

Consumer Services

Distribution Services

Health Technology

Finance

Ascot Plc

Health Services

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. David Hipkiss